Scailyte is courageous. We’ve stepped up to the challenge by developing a precise, predictive and trustworthy diagnostic test.
Using our proprietary AI driven cell analytics pipeline, we identified CTCL- specific biomarkers that accurately diagnose CTCL with >90% specificity and sensitivity.
This powerful diagnostic test will enable early intervention, improve patient’s quality of life, reduce treatment costs and most importantly, save lives.